Clinical trial
Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary…
NCT00023296 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00023296 |
|---|---|
| Title | Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension |
| Official title | Inhaled Nitric Oxide and Transfusion Therapy for Patients With Sickle Cell Anemia and Secondary Pulmonary Hypertension |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Collaborators | Mallinckrodt Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sickle Cell Anemia, Pulmonary Hypertension |
| Intervention type | Device, Drug |
| Interventions | Nitric Oxide, INO Pulse - NO Delivery System |
| Enrollment | 59 |
| Start date | Jul 27, 2001 |
| Primary completion | Nov 2, 2006 |
| Completion | Nov 9, 2015 |
| First posted | Sep 3, 2001 |
| Last update posted | Dec 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: